A University of Edinburgh spinout company, BioCaptiva, aims to revolutionise the early diagnosis of difficult-to-detect cancers with a new blood-based biopsy device.
University of Edinburgh biotech spinout BIOCAPTIVA has raised £1.58 million for its liquid biopsy technology.
At the University of Edinburgh we’ve created an entrepreneurial ecosystem to match our entrepreneurial mindset.
